A New Neurotech Startup Launches to Rival Sam Altman’s Merge Labs
Bridge Neurotech is planning to build a wearable brain-computer interface that uses ultrasound.
A new neurotech startup called Bridge Neurotech has emerged to challenge Sam Altman's Merge Labs in the burgeoning market of brain-computer interfaces. Founded by Will Biederman, a former co-founder of Arbor Neuroscience, Bridge aims to develop wearable devices that can interpret signals from the brain without requiring invasive surgery. Unlike Neuralink and other companies that focus on implanting chips directly into the brain, Bridge plans to use ultrasound technology for a less invasive approach.
Biederman's decision to start Bridge was driven by his vision of creating a device that could benefit a much larger population, rather than the limited number of individuals who can undergo brain surgery. He points out the significant risks and high safety standards necessary for implanted devices, emphasizing that many people are reluctant to undergo such procedures.
Current wearable interfaces have faced challenges with signal quality due to the weakening of electrical signals by bone and skin before they reach external sensors.
Bridge Neurotech's solution involves using ultrasound, which detects fluctuations in blood flow that correlate with neural activity. While this method introduces a delay of a few seconds between neural firing and blood flow changes, the company plans to employ predictive AI models to mitigate this lag and improve performance. The device, which resembles headphones and will be placed on the temporal window above the ear, will be tested in a clinical study involving both healthy adults and individuals who have undergone skull surgery.
Bridge's ultimate goal is to bring noninvasive brain-computer interfaces to both consumer and medical applications.
Written by urgent.news from Wired Science's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.